RT Journal Article
SR Electronic
T1 Is Lymphadenectomy Justified in Endometrial Cancer?
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP 507
OP 510
DO 10.1097/IGC.0b013e31820d3e06
VO 21
IS 3
A1 Dietl, Johannes
YR 2011
UL http://ijgc.bmj.com/content/21/3/507.abstract
AB Endometrial cancer has in the meantime become the most frequent malignant tumor of the female genital tract. With a 5-year survival rate of 82% for all stages and more than 90% for the most common stage I, it is a carcinoma with an excellent prognosis. Against this background and in light of the results of recent studies, the value of extensive surgical staging including pelvic and para-aortic lymphadenectomy beyond the standard therapy of hysterectomy with bilateral adnexectomy must be questioned.